Oman Medical Board Specialty (OMSB)   Report issue

Government Phase 3
Founded: Muscat Oman (2006)

Organization Overview

First Clinical Trial
2019
NCT04027322
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Oman Medical Board Specialty (OMSB) | Oman Medical Speciality Board

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Colic (Phase 3)

Pharyngitis (Phase 3)

Renal Colic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4